# Challenge fuels change.

The Medable of today outpaces industry benchmarks and delivers game-changing results, fueled by a culture that thrives on progress and perseverance. As the industry shifts, we’re leading the way, not just as a product innovator, but as a partner invested in your success.

Delivery

### 100%

On-time go-live

● All Studio deployments 100% on-time

Delivery

### 100%

On-time data transfers

● Rolling 3 months

Quality

### 90%

Patient eCOA adherence

● Rolling 12 months

Delivery

### 99%

Devices shipped on time

● Rolling 12 months

Help desk support

### 92%

First contact resolution

● Rolling 3 months

Delivery

### 5x

Faster study configuration

Delivery

### 35x

Faster first time eCOA creation than manual (no-code) build

Global access

### 120+

locales

> “So proud of our collaboration which is positively impacting this space of the industry.”

Global Head of Operations

GSK

## Better today, ready for tomorrow

### Product Innovation

By launching Medable AI, eCOA+, and Studio, we’ve streamlined trial execution, cut timelines by 50%, and automated critical tasks, empowering customers to focus on delivering life-changing therapies.

### Process Excellence

Our sharpened focus on operational excellence has transformed how we deliver. With 98% device success and 95% on-time launches, we’ve built a foundation of precision and reliability to hit critical trial milestones seamlessly.

### Partnership Culture

Through deep collaboration and patient-centric initiatives, we continue to build a culture of trust, innovation, and impact, ensuring every stakeholder benefits from meaningful progress.

## Expanding access to life changing treatments.

### Expanding global access

Medable currently operates in 70+ countries, enabling digital and decentralized trials worldwide, including regions such as Japan, France, and underserved remote areas.

### **Regional expertise and regulation support**

Medable became the first U.S.-based clinical trial platform provider to receive approval from France’s Commission Nationale de l’Informatique et des Libertés (CNIL) for its eConsent and eCOA solutions for a partner Sponsor company.

### **Expertise and patient input across diverse therapeutic areas**

Medable currently enables digital trials across 26 therapeutic areas and works with our expansive Patient Caregiver Network, which includes 90+ patient advocates and caregivers across 12 countries, representing 67 diverse health conditions.

## Experience the award-winning platform designed for sponsors, sites, and participants.

### Driving progress for sites, patients, and the industry.

Together with our partners and customers, we look forward to shaping the future of clinical research one breakthrough at a time to continue enabling treatments to patients faster.

Medable’s 2024 was a year of exceeding key milestones and helping our customers reach new heights. Take a look at the difference Medable has made with our year-end impact report.